Elanco Animal Health Inc. ELAN Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s deferred revenue?
- Elanco Animal Health Inc. (ELAN) reported deferred revenue of $400M in Q1 2026.
- How has Elanco Animal Health Inc.'s deferred revenue changed year-over-year?
- Elanco Animal Health Inc.'s deferred revenue increased by 25.4% year-over-year, from $319M to $400M.
- What is the long-term trend for Elanco Animal Health Inc.'s deferred revenue?
- Over 5 years (2020 to 2025), Elanco Animal Health Inc.'s deferred revenue has grown at a 7.1% compound annual growth rate (CAGR), from $295M to $416M.
- What does deferred revenue mean?
- Money received in advance for goods or services not yet delivered.
- How do you interpret deferred revenue?
- An increase suggests strong future demand or successful pre-selling of products, while a decrease indicates revenue recognition of previously deferred amounts.
- How does deferred revenue compare across companies?
- Common in companies with subscription models or long-term supply contracts.